Agenus Inc reports results for the quarter ended June 30 - Earnings Summary

Agenus

07/08/2026 22:31

Agenus Inc AGEN.OQ reported a quarterly adjusted loss of 1 cent​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.00.  The mean expectation of two analysts for the quarter was for earnings of 5 cents per share. 
Revenue rose 34.3% to $34.50 million from a year ago; analysts expected $34.00 million. 
Agenus Inc's reported EPS for the quarter was a loss of 1 cent​.
The company reported a quarterly loss of $600 thousand.
Agenus Inc shares had risen by 144.8% this quarter and gained 138.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 115.6% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Agenus Inc is $22.00, about 66% above its last closing price of $7.49
This summary was machine generated from LSEG data August 7 at 09:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.05
-0.01
Missed
Mar. 31 2026 
2.10
0.00
Missed
Dec. 31 2025 
-1.05
-0.31
Beat
Sep. 30 2025 
1.98
1.94
Missed